News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
863,639 Results
Type
Article (87561)
Company Profile (827)
Press Release (775231)
Multimedia
Podcasts (179)
Webinars (28)
Section
Business (233111)
Career Advice (4140)
Deals (39816)
Drug Delivery (141)
Drug Development (91292)
Employer Resources (203)
FDA (18302)
Job Trends (17407)
News (397516)
Policy (39932)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (133)
Alliances (56980)
ALS (147)
Alzheimer's disease (1695)
Antibody-drug conjugate (ADC) (269)
Approvals (18344)
Artificial intelligence (522)
Autoimmune disease (109)
Automation (30)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (168)
Biotechnology (485)
Bladder cancer (140)
Brain cancer (53)
Breast cancer (533)
Cancer (4238)
Cardiovascular disease (378)
Career advice (3562)
Career pathing (38)
CAR-T (259)
CDC (57)
Cell therapy (717)
Cervical cancer (33)
Clinical research (75953)
Collaboration (1462)
Company closure (4)
Compensation (982)
Complete response letters (64)
COVID-19 (2966)
CRISPR (87)
C-suite (632)
Cystic fibrosis (142)
Data (5113)
Decentralized trials (2)
Denatured (65)
Depression (116)
Diabetes (472)
Diagnostics (7116)
Digital health (38)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (249)
Drug pricing (196)
Drug shortages (36)
Duchenne muscular dystrophy (210)
Earnings (99502)
Editorial (56)
Employer branding (25)
Employer resources (172)
Events (133709)
Executive appointments (1000)
FDA (20914)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (18)
Funding (1313)
Gene editing (184)
Generative AI (52)
Gene therapy (575)
GLP-1 (1049)
Government (5398)
Grass and pollen (8)
Guidances (375)
Healthcare (20940)
HIV (49)
Huntington's disease (41)
IgA nephropathy (75)
Immunology and inflammation (263)
Immuno-oncology (22)
Indications (61)
Infectious disease (3220)
Inflammatory bowel disease (193)
Inflation Reduction Act (16)
Influenza (104)
Intellectual property (202)
Interviews (816)
IPO (17933)
IRA (59)
Job creations (5197)
Job search strategy (2866)
Kidney cancer (17)
Labor market (82)
Layoffs (643)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (13)
Lung cancer (600)
Lymphoma (290)
Machine learning (33)
Management (66)
Manufacturing (676)
MASH (152)
Medical device (14918)
Medtech (14947)
Mergers & acquisitions (22805)
Metabolic disorders (1220)
Multiple sclerosis (143)
NASH (23)
Neurodegenerative disease (240)
Neuropsychiatric disorders (64)
Neuroscience (2783)
NextGen: Class of 2025 (7707)
Non-profit (5098)
Now hiring (60)
Obesity (586)
Opinion (317)
Ovarian cancer (146)
Pain (173)
Pancreatic cancer (183)
Parkinson's disease (248)
Partnered (32)
Patents (435)
Patient recruitment (346)
Peanut (57)
People (66382)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23426)
Phase II (32959)
Phase III (24856)
Pipeline (3074)
Policy (306)
Postmarket research (3554)
Preclinical (10592)
Press Release (72)
Prostate cancer (207)
Psychedelics (52)
Radiopharmaceuticals (283)
Rare diseases (718)
Real estate (7423)
Recruiting (79)
Regulatory (28175)
Reports (65)
Research institute (2700)
Resumes & cover letters (651)
Rett syndrome (18)
RNA editing (15)
RSV (77)
Schizophrenia (140)
Series A (215)
Series B (160)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (170)
Sponsored (42)
Startups (4320)
State (2)
Stomach cancer (17)
Supply chain (103)
Tariffs (96)
The Weekly (112)
Vaccines (1071)
Venture capital (69)
Weight loss (414)
Women's health (63)
Worklife (21)
Date
Today (220)
Last 7 days (1340)
Last 30 days (3538)
Last 365 days (33614)
2025 (29175)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1284)
Alabama (81)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (51104)
Australia (8983)
California (10108)
Canada (2968)
China (967)
Colorado (422)
Connecticut (447)
Delaware (290)
Europe (117495)
Florida (1478)
Georgia (327)
Hawaii (3)
Idaho (67)
Illinois (834)
India (56)
Indiana (494)
Iowa (20)
Japan (340)
Kansas (127)
Kentucky (39)
Louisiana (27)
Maine (80)
Maryland (1341)
Massachusetts (7547)
Michigan (322)
Minnesota (594)
Mississippi (4)
Missouri (126)
Montana (33)
Nebraska (26)
Nevada (110)
New Hampshire (81)
New Jersey (2785)
New Mexico (32)
New York (2705)
North Carolina (1461)
North Dakota (10)
Northern California (4691)
Ohio (311)
Oklahoma (22)
Oregon (51)
Pennsylvania (2075)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (52)
South Dakota (1)
Southern California (3849)
Tennessee (153)
Texas (1572)
United States (36973)
Utah (301)
Virginia (258)
Washington D.C. (84)
Washington State (856)
West Virginia (4)
Wisconsin (105)
Wyoming (2)
There are 863,639 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cardiovascular disease
Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial
The cholesterol-lowering drug is part of a suite of medicines that also includes MariTide and that Amgen Chief Medical Officer Paul Burton hopes will make the company the “undisputed leader in the management of cardiometabolic risk for patients” by 2030.
November 10, 2025
·
4 min read
·
Heather McKenzie
Metabolic disorders
Lilly Makes $1.2B RNAi Pact With SangeneBio, Targets Metabolic Diseases
Eli Lilly has been on a dealmaking spree this year, with a few deals worth $1 billion or more. Aside from SangeneBio, these include SiteOne, Verve and Scorpion.
November 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
November 10, 2025
·
1 min read
Press Releases
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
November 10, 2025
·
22 min read
Press Releases
Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo
November 10, 2025
·
2 min read
Press Releases
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
November 10, 2025
·
1 min read
Cardiovascular disease
Merck Builds Case for Cholesterol-Lowering Pill With Injectable-Like Efficacy
Multiple analyst firms were impressed by the Phase III data, which showed that Merck’s oral PCSK9 inhibitor can lower low-density lipoprotein cholesterol by more than 55% after 24 weeks.
November 10, 2025
·
2 min read
·
Tristan Manalac
Press Releases
InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)
November 10, 2025
·
20 min read
Press Releases
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
14 min read
Press Releases
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
November 10, 2025
·
13 min read
1 of 86,364
Next
